Radcom Ltd. (NASDAQ: RDCM) reported Q4 EPS of $0.21, may not compare to the analyst estimate of $0.09. Revenue for the quarter came in at $10.6 million versus the consensus estimate of $10.54 million.

• Both GAAP and non-GAAP results for the fourth quarter of 2017 included a $1.1 million, or $0.08 per diluted share, benefit related to grants from the Israel Innovation Authority (formerly Office of the Chief Scientist), compared to $552,000, or $0.05 per diluted share, in the fourth quarter of 2016.

For earnings history and earnings-related data on Radcom Ltd. (RDCM) click here.